Patients with noncancerous adrenal tumors don’t need repeated imaging or hormone tests; they are most likely to succumb to hypertension, dyslipidemia, and type 2 diabetes, suggests a new meta-analysis.
Medscape Medical News
Patients with noncancerous adrenal tumors don’t need repeated imaging or hormone tests; they are most likely to succumb to hypertension, dyslipidemia, and type 2 diabetes, suggests a new meta-analysis.
Medscape Medical News